Related Experiment Video
Updated: May 3, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
21.0K
A New Bliss Independence Model to Analyze Drug Combination Data
Wei Zhao1, Kris Sachsenmeier2, Lanju Zhang3
1MedImmune LLC, Gaithersburg, MD, USA Zhaow@MedImmune.com.
Journal of Biomolecular Screening
|February 5, 2014
Summary
The Bliss independence model for drug synergy lacks statistical rigor, often leading to false positives. A new two-stage response surface model offers robust statistical testing for drug interactions, reducing false claims and identifying true synergy regions.
Area of Science:
- Pharmacology
- Biostatistics
- Computational Biology
Background:
- The Bliss independence model is a common method for analyzing drug combination screening.
- It compares observed responses to predicted responses assuming no drug-drug interactions.
- Current methods often lack statistical rigor, leading to false-positive synergy claims.
Purpose of the Study:
- To introduce a statistically rigorous method for analyzing drug interactions.
- To reduce false-positive claims in drug synergy screening.
- To identify statistically significant synergy regions for drug combinations.
Main Methods:
- Development of a two-stage response surface model.
- Statistical testing for drug synergism across all dose combinations.
- Application to drug combinations targeting EGFR and IGF-1R.
Main Results:
- The proposed model provides robust statistical testing for drug interactions.
- It significantly reduces the risk of false-positive synergy claims.
- Identified statistically significant synergy regions for specific drug combinations.
Conclusions:
- The two-stage response surface model offers a more reliable approach to drug synergy analysis.
- This method enhances the accuracy of identifying effective drug combinations.
- It has implications for drug discovery and development, particularly in oncology.
Related Concept Videos
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
727
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
727
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
119
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
119
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
426
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
426
01:14Model Approaches for Pharmacokinetic Data: Compartment Models
888
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
888
01:26Pharmacokinetic Models: Comparison and Selection Criterion
490
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
490
01:27Combined Effects of Drugs: Synergism
6.2K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.2K